155905-76-3

Basic information

• Product Name: (S)-1-Boc-azepane-2-carboxylic acid
• Synonyms: (S)-1-Boc-azepane-2-carboxylic acid;(2s)-1-[(tert-butoxy)carbonyl]azepane-2-carboxylic acid
• CAS NO: 155905-76-3
• Molecular Formula: C₁₂H₂₁NO₄
• Molecular Weight: 243.31
• EINECS: -0
• Mol File: 155905-76-3.mol
• Article Data: 9

Chemical Properties

• Melting Point: 110-112 °C
• Boiling Point: 369.0±35.0 °C(Predicted)
• Appearance: /
• Density: 1.133±0.06 g/cm3(Predicted)
• PKA: 4.03±0.20(Predicted)
• CAS DataBase Reference: (S)-1-Boc-azepane-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-Boc-azepane-2-carboxylic acid(155905-76-3)
• EPA Substance Registry System: (S)-1-Boc-azepane-2-carboxylic acid(155905-76-3)

Safety Data

• Hazardous Substances Data: 155905-76-3(Hazardous Substances Data)

Usage

General Description

(S)-1-Boc-azepane-2-carboxylic acid is a chemical compound that belongs to the class of azepane derivatives. It is a white to off-white solid with a molecular formula C11H19NO4 and a molecular weight of 233.27 g/mol. (S)-1-Boc-azepane-2-carboxylic acid is commonly used as a building block in the synthesis of various pharmaceuticals and bioactive compounds. It is also utilized in organic chemistry as a chiral auxiliary for asymmetric synthesis. Additionally, (S)-1-Boc-azepane-2-carboxylic acid possesses potential biological activities and is being studied for its potential pharmacological uses.

Upstream product

• 124-38-9 carbon dioxide 
• 123387-52-0 N-Boc-perhydroazepine 
• 1034708-26-3 1-(tert-butoxycarbonyl)-azepane-2-carboxylic acid 
• 5227-53-2 (2R/S)-azepinecarboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 208522-13-8 (S)-2-N-(tert-butoxycarbonyl)-2-amino-5-hexenoic acid 
• 90989-12-1 (2S)-2-amino-5-hexenoic acid 
• 116611-45-1 (2R)-2-t-butoxycarbonylamino-3-phenylsulfonyl-1-(2-tetrahydropyranyloxy)propane 
• 178172-25-3 tert-butyl 2,3,4,5-tetrahydro-1H-azepine-1-carboxylate 
• 546141-51-9 tert-butyl (3S,5S,6R)-3-(5-chloropentyl)-2-oxo-5,6-diphenyl-4-morpholinecarboxylate 
• 546141-52-0 (3S,5S,6R)-3-(5-Chloro-pentyl)-5,6-diphenyl-morpholin-2-one 
• 546141-53-1 (3R,4S,10aS)-3,4-diphenyloctahydro-1H-[1,4]oxazino-[4,3-a]azepin-1-one 
• 60274-60-4 1-chloro-5-iodopentane 
• 66865-37-0 (S)-perhydro-2-azepinecarboxylic acid 

Downstream Products

• 546141-60-0 (S)-Azepane-1,2-dicarboxylic acid 2-((R)-1-benzyloxycarbonyl-ethyl) ester 1-tert-butyl ester 
• 66865-37-0 (S)-perhydro-2-azepinecarboxylic acid 
• 546141-58-6 C₆₄H₉₀N₄O₁₅ 
• 546141-59-7 1-[2-(4-methyl-2-{methyl-[2-(4-methyl-2-{methyl-[2-(4-methyl-2-methylamino-pentanoyloxy)-3-phenyl-propionyl]-amino}-pentanoyloxy)-propionyl]-amino}-pentanoyloxy)-3-phenyl-propionyl]-azepane-2-carboxylic acid 1-benzyloxycarbonyl-ethyl ester 
• 546141-57-5 N-methyl-L-leucyl-3-phenyl-D-lactyl-N-methyl-L-leucyl-D-lactyl-N-methyl-L-leucyl-3-phenyl-D-lactyl-L-azepanyl-D-lactic acid 
• 546141-55-3 benzyl L-azepanyl-D-lactate 

Relevant articles and documents

Polybasic nitrogen heterocyclic non-natural chiral amino acid and synthesis method thereof

The invention relates to a polybasic nitrogen heterocyclic non-natural chiral amino acid and a synthesis method thereof. The amino acid can be applied to molecule building for antibiotic synthesis. According to the synthesis method, 2-aminodiethyl malonate and halogenated alkanes carry out substitution reactions, cyclization reactions, and decarboxylation reactions, and the reaction products are split to obtain the polybasic nitrogen heterocyclic non-natural chiral amino acid. The provided novel synthesis method has the advantages of simple synthesis route, low cost, convenient operation, andeasiness for commercial production, the chiral purity of obtained products is high, and the application prospect is good.

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

HETEROCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.